An estimated third of the world's population is latently infected with Mycobacterium tuberculosis (Mtb), with no clinical signs of tuberculosis (TB), but lifelong risk of reactivation to active disease. The niches of persisting bacteria during latent TB infection remain unclear. We detect Mtb DNA in peripheral blood selectively in long-term repopulating pluripotent hematopoietic stem cells (LT-pHSCs) as well as in mesenchymal stem cells from latently infected human donors. In mice infected with low numbers of Mtb, that do not develop active disease we, again, find LT-pHSCs selectively infected with Mtb. In human and mouse LT-pHSCs Mtb are stressed or dormant, non-replicating bacteria. Intratracheal injection of Mtb-infected human and mouse LT-pHSCs into immune-deficient mice resuscitates Mtb to replicating bacteria within the lung, accompanied by signs of active infection. We conclude that LTpHSCs, together with MSCs of Mtb-infected humans and mice serve as a hitherto unappreciated quiescent cellular depot for Mtb during latent TB infection.
Introduction
Tuberculosis (TB) is a major infectious disease in humans, caused by Mycobacterium tuberculosis (Mtb), with 9.6 million active cases reported in 2014. A much larger part of the world's population is, in addition, latently TB-infected (LTBI), with no clinical signs of disease, but lifelong risk of reactivation. Mtb can enter dormancy, thereby persisting in the human host despite a strong immune response [1, 2] . How, where, and under what circumstances Mtb is retained in the host during LTBI, and how it could undergo resuscitation and cause active TB, remain important but unresolved questions [3] [4] [5] . We test the hypothesis that in LTBI Mtb bacteria acquire a non-replicating state inside resting, long-term repopulating pluripotent hematopoietic stem cells (LT-pHSCs) [6] . LT-pHSCs tolerate hypoxia [7, 8] , lack tuberculocidal activity a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 mediated by endogenous reactive oxygen and nitrogen species [9, 10] , and tune down immune surveillance mechanisms of the host [11] . In addition, they tune down immune-stimulating mechanisms of Mtb, if Mtb are able to acquire dormancy from the host [1, 4, 6] .
Here, we detect Mtb DNA in human peripheral blood, selectively accumulated in a portion of CD34 +   CD90   +   CD38 -pHSCs [12, 13] , as well as previously reported CD271 + CD45 -mesenchymal stem cells (MSCs) [14, 15] , from individuals with LTBI determined by IFN-γ release assay (IGRA) [16] . In mice that harbor Mtb, but do not develop TB, we, again, identified a portion of LT-pHSCs in bone marrow [17, 18] selectively infected with Mtb. Mtb in human and mouse pHSCs express stress or dormancy genes and do not form colonies on agar [19, 20] . Intratracheal application of human and mouse pHSCs harboring Mtb into immune-deficient mice resuscitates Mtb replication accompanied by increased cellularity indicative of an inflammatory infiltrate, typically observed when these mice are infected with replicating Mtb. LT-pHSCs are thought to reside in hypoxic niches of bone marrow in close contact with other hematopoietic and non-hematopoietic cells, e.g. mesenchymal stem cells (MSCs) [7, 8, 21] , that provide the supportive microenvironmental niche for HSCs [22] . Das et al. have reported that human bone marrow CD271 + CD45
− MSCs in vitro as well as an equivalent population of bone marrow MSCs in the mouse may provide a long-term protective intracellular niche in the host in which Mtb can reside [23, 24] . The quiescence of the hypoxic niche of mesenchymal and hematopoietic cells could provide stress and induce dormancy genes of Mtb [25] [26] [27] .
Our findings suggest that Mtb-infected bone marrow-derived hematopoietic stem cells of mice and humans, together with Mtb-infected MSCs serve as a hitherto unappreciated cellular niche during LTBI, capable of resuscitating active TB disease. Mtb-infected, blood-borne LTpHSCs can be used to diagnose LTBI, and to monitor drug treatments. Their existence challenges current hypotheses of TB pathogenesis and epidemiology. (Table 1) . We also isolated pHSCs by their drug efflux properties as Hoechst low/ negative side population (SP) phenotype cells (S1A Fig) , since pHSCs are highly enriched in SP cells [28, 29] . DNA of all these potentially Mtb-infected cells was used to PCR-amplify DNA fragments of Mtb-encoded sequences to search for Mtb infection and Bacille Calmette-Guérin (BCG)-encoded sequences to score for possible remnants of a BCG-vaccination (Fig 1A-1E) [30, 31] .
Results

Human
Eight of eight IGRA + donors scored positive in blood cells for Mtb (Fig 1A-1E) , and none of them positive for BCG (Donors 8-13; Fig 1B) (Fig 1A-1F) . Thus, potentially only one of five Mtb DNA copies detected in Lin  -CD34  + and Lin  -CD34  + CD90  + CD38  -cells was replication-competent, the majority were non-replicative in quiescent hematopoietic cells. Furthermore, from lysates of 10 3 CD271 + CD45 -MSCs no CFUs were detected (Fig 1F) .
Therefore, in the donors tested the majority of Mtb DNA copies detected in CD271 + CD45 -MSCs cells were similarly not replication-competent. Next, we infected mice with Mtb to see whether bone marrow-derived LT-pHSCs could become carriers of the bacterium too. We used a mouse model of intradermal ear infection, where low numbers of Mtb persist systemically without developing active TB typically seen after aerosol infection of mice with Mtb [5] . A variety of organs, such as the lung, and the spleen, but not the thymus, and hematopoietic cells in them were found to be infected 28 days post-infection (p.i.). DNA purified from 10 5 lung cells harboured between one and ten copies of Mtb DNA (Fig 2A and 2C) . [36] were found to harbor between 40 and 100 copies of Mtb DNA, as detected by qPCR targeting MPB64 and IS6110 and in limiting dilution analyses targeting IS6110 alone (Fig 2A-2B; S2B Fig) . In MPB64 qPCRs LT-pHSCs were found to harbor between five and 90 copies of Mtb DNA ( Fig  2C) . By contrast, in 10 [36] , no Mtb DNA could be detected using any of these PCR analyses (Fig 2A and 2C) . dendritic cells, Gr1 + granulocytes and CD19 + cells identifying B as well as dendritic cells, representing 10 to 100-fold lower numbers of Mtb DNA copies than in LT-pHSCs (Fig 2A and  2C ). We have not attempted to purify MSCs from bone marrow of infected mice. We conclude that intradermal infection of mice resulted in Mtb-infected LT-pHSCs in bone marrow 28 days p.i., and that during this infection, similarly to our observations in human LTBI, only LT-pHSCs harbored Mtb DNA among specific pHSC populations. Nevertheless, in this mouse model, the lung and more mature Lin + cells in spleen and bone marrow of mice are infected with Mtb detected by qPCR and CFU assays, which is in contrast with our observations in human LTBI. Accordingly, we do not suggest that this mouse infection model, at day 28 p.i., is comparable to the pathophysiological status of latent infections in LTBI. Nevertheless, the selective Mtb infection of LT-pHSCs over ST-pHSCs and MPPs was recapitulated in our mouse model.
Numbers of replication-competent, colony-forming Mtb in Mtb-infected mouse cells
We tested the different Mtb-DNA + cell populations for replication-competent, active Mtb measured by enumerating CFUs (Fig 2D-2F (Fig 2C and 2F) . Thus, up to 80% of Mtb DNA in LT-pHSCs were not replication-competent as assayed by CFUs. Our results also suggest that not all, but only a part, of the LT-pHSC pool is infected by Mtb, almost all of which were in a quiescent stage. However, these analyses do not reveal the number of infected cells in the pHSC pool.
Next we directly visualized LT-pHSCs carrying Mtb by rhodamine-auramin staining [37] . In LT-pHSCs, Mtb was readily detectable, whereas ST-pHSCs and MPPs did not show positive staining (Fig 3) . Approximately one to six of~10 3 analyzed LT-pHSCs stained positive for Mtb (Fig 3) . As a control Mtb-infected lung cells were analyzed. In these cells the number of Mtb positive cells as revealed by rhodamine-auramin staining, qPCR and CFU were showing a good correlation (Figs 3 and 4) . However, this staining method was not as sensitive as qPCR in determining the actual number of LT-pHSCs harbouring Mtb [38] .
Mtb residing within human CD34
+ as well as mouse CD150 + pHSCs express genes of the dormancy regulon Since 10 3 mouse LT-pHSCs were found to contain between five and 90 copies of Mtb genomes, but generated only 10 CFUs (Figs 2C, 2F and 4), we concluded that the vast majority, i.e. around 80%, of Mtb bacterial genomes persist in a non-replicating form. Dormancy or stress of Mtb is induced under hypoxic conditions and is reflected in a change of gene expression [25] [26] [27] . It is controlled by the dormancy regulon and involves transcription of approximately 50 so-called dormancy genes, among them DosR, c-lat and hspX [19, [25] [26] [27] . SigA is expressed in non-replicating as well as in replicating, CFU-forming Mtb and thus, can be used as a housekeeping gene [20] .
We hypothesized that the hypoxic niche of LT-pHSCs, by being stressed, could induce dormancy of Mtb [7, 8] . To test for this hypothesis, we performed quantitative RNA expression analyses for Mtb dormancy genes in mouse LT-pHSCs as well as in Mtb-infected lung cells 28 days p.i., in which the vast majority of Mtb organisms form CFUs (Fig 4) . (Fig 1A and 1D; S4 Fig) , Lin -CD150 + CD48 -LT-pHSCs from bone marrow of infected mice (Fig 2A and 2C) , containing between 5 and 90 ( Fig 2C) copies of Mtb-DNA as well as 100 pure, replication-competent Mtb as control, were administered into the trachea of Rag2 -/-Il2rg -/-mice and organs were analyzed 3 weeks later (Fig 6A) . Mtb DNA as well as active, replicating Mtb CFUs were detected in the lungs (Fig 6B and 6C) . Between 100 and 400 CFUs were detected in total lung cells of mice receiving human LT-pHSCs, while in lungs of mice receiving mouse LT-pHSCs contained between 50 and 200 CFUs. Hence, Mtb contained in pHSCs had expanded between 10 and 100-fold as active, replicating bacteria. Active, replicating Mtb was also detected in spleen, thymus, and bone marrow in mice recieving pHSCs from IGRA + donors and Mtb-infected mice, but not in mice recieving Lin + cells from IGRA + donors or cells from IGRA − donors (Fig 6B-6C ).
We conclude from these results, that Mtb replicated in the lungs of mice, into which Mtbinfected human or mouse pHSCs had been transferred. These expanded Mtb were replication -competent and had spread systemically. However, while in total bone marrow cells of the recipient mice Mtb DNA and replicating Mtb CFUs were detectable (Fig 6C) , pHSCs of the donors (human or mice) could not be detected by FACS in the bone marrow of the recipient. This suggests, that bone marrow infection was caused by a dissemination of replication-competent Mtb from the lung resulting from a primary infection, rather than by Mtb-infected donor pHSCs homing from lung to bone marrow.
In histological sections of lungs of the Rag2 -/-Il2rg -/-mice transplanted with either human pHSCs from LTBI or mouse pHSCs from Mtb-infected mice, we observed increased cellularity in the lungs indicative of an inflammatory infiltrate in response to an active infection 3 weeks after pHSC transfer (Fig 6D) . Transfer of Lin + cells from IGRA + donors and cells from IGRA − donors did not induce these histological changes in the lung of recipients. The observed increase in cellularity in the lung could result from the expansion of replication-competent Mtb or from both replication-competent and stressed dormant bacteria. In the latter case, stressed dormant Mtb could be resuscitated to active replicating bacteria. In any case, we conclude that Mtb-infected human and mouse pHSCs can reproduce an active infection after introduction into recipient mice by intratracheal transfer.
Discussion
Our results suggest that, in individuals with LTBI, dormant Mtb bacteria reside, and perhaps transit, between long-lived, resting hematopoietic and non-hematopoietic cells in hypoxic niches (Fig 7) [6-8, 40] . We have interpreted the expression of DosR, hspX and c-Lat genes as a sign of either stress or dormancy of Mtb, both induced in hypoxic areas of bone marrow that are thought to promote energy saving, and thus, could favor long-term rest of both LT-pHSCs and Mtb. If so, do the energy-saving gene expression programs of both Mtb and host pHSCs interact with each other [4, 19] ? Future whole transcriptome next-generation sequencing of Mtb-as well as of LT-pHSCencoded genes expressed in single LT-pHSCs will not only allow monitoring of Mtb-but also of LT-pHSC-controlled gene expression programs and their potential for interactions in hypoxic stem cell niches of bone marrow. It will also provide more precise information on the number of LT-pHSCs infected by either replicative or dormant Mtb. If Mtb and LT-pHSCs adapt to each other by dormancy, it is conceivable that other facultative intracellular bacteria could find the same long-term quiescent niche for long-term persistence in a dormant state.
The possibility of a transfer of Mtb from infected bone marrow donors has been made likely in several case reports that have described incidence of Mtb infections between 120 days and 20 months post allogenic bone marrow transfer. However, these reports only refer to the induction of an Mtb infection as a consequence of the administration of immunosuppressive drugs to the recipients [41] [42] [43] [44] [45] . While patients that receive an allogeneic pHSC transfer, or that are scheduled to be treated with anti-inflammatory agents such as anti-TNFα antibodies, are usually tested for their IGRA-status prior immunosuppressive treatment, pHSCs are not screened for possible infections. Our results suggest that bone marrow donors should be screened for Mtb infection, so that they can be cured of the infection prior to bone marrow transplantation.
Within the limited numbers of human donors with LTBI, that were available to us, all of them carried Mtb exclusively in pHSCs. Two of them were also analysed for the presence of Mtb in MSCs, and both were positive. However, a much larger number of LTBI donors should be screened to evaluate, whether a small percentage of LTBI donors could be free of Mtb in their pHSCs. Such a larger analysis could also test the possibility, that a low percentage of LTBI donors could carry Mtb in the progeny of pHSCs, e.g. in MPPs, CMPs or CLPs.
A host with LTBI has immunological memory for Mtb [2] . Therefore, resuscitation of TB will only be successful if the immune system of the LTBI host fails to eliminate cells, in which actively replicating Mtb have been resuscitated from a stressed or dormant state. This can be readily observed in patients with inborn or acquired immunodeficiencies, e.g. in HIV-infected patients or patients treated with TNFα-inhibitors. The precise stimuli leading to reactivation require further investigation. However, the consequences of pHSCs spreading active Mtb throughout the body, either directly or after differentiation, can be detrimental. Our data thereby provide an additional explanation for the possible occurrence of reactivated TB in other bodily organs after primary infection and encapsulation in granulomas.
Materials and Methods
Human samples
Latently Mtb infected subjects included in the study were from a Western country, had not been treated previously for tuberculosis (TB), had normal chest radiography and were not suffering from active TB. Hence, LTBI individuals were routinely identified by positive IGRA (Quantiferon-TB Gold 1 test, Cellestis, Qiagen) and exclusion of active TB. IGRA testing was performed either because of a scheduled treatment with TNF-α inhibitors or because of occupational contact with patients suffering from active pulmonary TB. Collection of blood samples was approved by the Ethics Committee of the Medical University of Vienna (EK 071/2005) and conducted according to the Declaration of Helsinki. Informed written consent was obtained from all patients.
Mice
C57BL/6 wild-type mice were purchased from Charles River Laboratories. CD45.1 C57BL/6 and Rag2
Il2rg
-/-mice were bred in our facilities. Infected mice were maintained at biosafety 
Infection with Mtb
Mtb strain H37Rv was cultured in Middlebrook 7H9 broth (BD) supplemented with 0.05% (v/v) Tween 80 and Middlebrook AODC Enrichment (BD) to mid-log phase (OD 600 nm 0.6-0.8). Bacteria were harvested, resuspended in PBS (GIBCO), and frozen at -80˚C until use. For dermal infections, 8-to 10-week-old female C57BL/6 wild-type mice were anesthestized by i.p. administration of ketamine (50 mg/kg) and Rompun (5 mg/kg; Bayer), and 10
5 Mtb in 50 μl PBS were administered into the ear dermis. Mice were monitored daily regarding their health, body condition and well-being. Specifically, we monitored mice for loss of body weight, abdominal respiration and lesions of ear dermis. Once a week mice were weighed. At the end of experiment mice were sacrificed by cervical dislocation. For the infection of human monocytic leukemia cells in vitro, THP-1 cells (ATCC 1 TIB-202™, ATCC cell lines, UK) were used, that were authenticated by STR profiling and tested for mycoplasma contamination. We have not used any cell line from the list of commonly misidentified cell lines (ICLAC). THP-1 cells were seeded in T 75 flasks (TPP) in complete RPMI-1640 (cRPMI, RPMI-1640 medium supplemented with 1% L-glutamine, 1% Hepes, 0.1% 2-ME and fetal bovine serum to a final concentration of 10%; GIBCO, Life Technologies). For proper viability of cells, a concentration of 1 × 10 6 cells/ml was not exceeded. Cells were incubated at 37˚C and 5% CO 2 . Differentiation to macrophages was triggered by overnight incubation with PMA (50 ng/ml), followed by two washes in RPMI-1640 and addition of cRPMI-1640 over 48 h post-differentiation. For infection, 10 7 differentiated macrophages were seeded into T 150 flasks in 25 ml cRPMI and 1 ml of medium containing 10 5 Mtb was added. Non-internalized bacteria were washed away 4 h p.i.
using PBS and cells were placed back in cRPMI. Cells were harvested for RNA isolation 48 and 96 hours p.i. 
Antibodies
Hoechst staining
Human PBMC were resuspended in SP buffer (HBSS, 2% FCS, 2mM HEPES buffer; GIBCO, Life Technologies), prewarmed to 37˚C and incubated with Hoechst 33342 (Molecular Probes, Life Technologies) at 5 μg/ml for 2 h at 37˚C. All subsequent steps were carried out on ice. Cells were stained with antibodies against lineage markers as described above. 7-AAD (5 μg/ ml, Calbiochem) was added for live-dead cell discrimination. As negative control, PBMCs were preincubated with verapamil (100 μM, Sigma Aldrich). Cells showing a dim staining in the Hoechst blue (450/50 nm band pass filter) and Hoechst red (660/20 nm) channels were sorted to a purity >98% on a FACS ARIA (BD Biosciences).
Mtb DNA detection
We used the mycobacterial DNA extraction procedure first described by [46] , using the SYBR green system of detection. Primers for human 5 0 -CTCC CCACACACATGCACTTA-3 0 and 5 0 -CCTAGTCCCAGGGCTTTGATT-3 0 and mouse GAPDH 5 0 -CATGTTCCAATATGATTCCAC-3 0 and 5 0 -CCTGGAAGATGGTGATG-3 0 were used as endogenous controls for eukaryotic cells. H37Rv DNA was used to construct a standard curve for primers used. PCR products were detected as an increase in fluorescence with the ABI PRISM 7700 instrument and quantified using the SDS software, version 2.2.2.
In order to reduce amplification backgrounds with primers, we have performed quantitative PCR analyses using a "no template = water control" for every run. Exponential amplification in the "water control" with Ct values of 51-55 was taken as the detection limit for Mtb in PCRs targeting IS6110 and MPB64 together. In PCRs targeting MPB64 alone, "water control" Ct values of 48-50 was taken as the detection limit. To ensure that this background did not result from a contamination by genomic Mtb DNA, the MPB64 qPCR product was analyzed by gel electrophoresis. While the expected PCR product size was detectable in the Mtb + samples, such a distinct PCR band were not found in the "water control" (S3 Fig and 5 0 -GCGTAGGCGTCGGTGACAAA-3 0 were used to amplify a 245-bp DNA fragment encoded by the IS6110 insertion sequence in the Mtb genome [30] . At the point where the PCR signal was lost in serial dilutions, limiting dilution analyses were performed.
Mtb-specific and BCG-specific DNA was also detected using primers previously described [31] . PCR reactions were performed in a thermal cycler at 95˚C for 15 min, followed by 50 cycles at 95˚C for 30 s, 45 s at different annealing temperatures and 45 s at 72˚C (DNA Engine 1 PTC2000, Biozym DiagnosticRad). For every reaction uninfected DNA and DNA from H37Rv Mtb were included. PCR products were analyzed by electrophoresis on 2% agarose gels.
Colony-forming units
Mice were sacrificed at 28 days p.i., and organs (spleen, thymus, lung and bone marrow) were aseptically removed and homogenized in 1 ml PBS containing 0.05% Tween 80 (v/v). For pulmonary CFU determination, the lung was removed and incubated in 1 mg/ml collagenase type VIII (Sigma-Aldrich) and 30 μg/ml DNase I (Roche) at 37˚C for 30 min. One half of each of the lung homogenate, the spleen, and the thymus were diluted in PBS containing 0.05% v/v Tween 80 and plated onto Middlebrook 7H11 agar plates supplemented with Middlebrook OADC Enrichment (Dibco). In addition, purified human and mouse pHSCs were plated. CFUs were enumerated after 4-6 weeks of incubation at 37˚C and 5% CO 2 .
RNA/qRT-PCR
Cells were homogenized in TRIzol (Invitrogen) and RNA was isolated via chloroform extraction (Life Technologies), treated with ethanol and dissolved in RNase-free water. RNA from Mtb infected THP-1 cells was isolated as previously described [47, 48] . One hundred ng of total RNA was reverse-transcribed by SuperScript III (Invitrogen) primed with oligodT. The cDNA for the specific target assays was then amplified by pre-amplification reaction using pooled gene-specific primers according to the manufacturer's protocol (Invitrogen). The pre-amplification product was diluted [1:20) and finally analyzed by real-time TaqMan 1 PCR using the following TaqMan probes: DosR, c-lat, hspX and SigA (Design Batch ID: w1406535517000, order number: 2106064SO, Invitrogen). DosR, c-lat and hspX RNA abundances were normalized to SigA as endogenous controls for Mtb. Each sample was assayed in triplicate. H37Rv DNA was used to construct a standard curve for all inspected genes. The PCR product was detected as an increase in fluorescence with the ABI PRISM 7700 instrument. RNA was quantified using the SDS software, version 2.2.2.
Cytology
Sorted cells were fixed in PBS containing 4% w/v PFA for 24 h at 4˚C. Thereafter, cells were immobilized by cytospin on a solid support (Shandon Centrifuge, Modell Cytospin 3). Slides were flooded with auramine-rhodamine for 15 min, fluorescent decolorizer for 2-3 min and potassium permanganate for 3-4 min. A 2-μg/ml working solution of DAPI was used for nuclear visualization. Cover slips were mounted in ProLong Gold anti-fade reagent (Cat. No. P36934; Invitrogen) and sealed using adhesives. Slides were screened with 100× (for images) objectives under oil immersion using a fluorescence microscope (DMRB Fluorescence Microscope, Leica Microsystems). Analyses using the fluorescence microscope were done using ProGres Capture Pro 2.8. 
Histology
For histology, lung caudal lobes were preserved in PBS containing 4% w/v PFA for 24 h at 4˚C, embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Slides were screened with 5× objectives on a light microscope (Leica DMLB, Leica Microsystems). Analyses were done using ProGres Capture Pro 2.8.8. (Optical Systems, Jenoptick AG). 
Intratracheal administration of Mtb-infected pHSCs
Il2rg
-/-mice were anesthetized by i.p. administration of ketamine (50 mg/kg) and Rompun (5 mg/kg). Thereafter, using a micropipette, 100 CFU of Mtb H37Rv, 1,000 pHSCs of uninfected and Mtb-infected mice at day 28 p.i., or 1,000 Lin + cells and pHSCs of human IGRA + as well as IGRA − donors diluted in 50 μl of sterile PBS were gently placed in the trachea of each mouse. Mice were monitored daily for loss of body weight and abdominal respiration. Mice were sacrificed by cervical dislocation 3 weeks posttransfer and lungs were analyzed for Mtb-specific DNA, CFUs and histologically.
Statistics
For all statistical analyses, PRISM (Version 6, GraphPad, San Diego) software was used. Dispersion is presented as the median + interquartile, unless stated otherwise. Statistical analysis was performed with Mann-Whitney two-tailed test. P values <0.05 were considered significant. from IGRA + donors was tested by PCR. Quantification of Mtb-specific DNA was done by realtime TaqMan PCR using probes that target MPB64 and IS6110 together as well as real-time SYBR green PCR using primers that target MPB64 alone. PCRs were performed in technical triplicates and normalized to human GAPDH (median + interquartile). Due to a lack of sufficient DNA material we were not able to include single-target qPCRs on donors 8 and 9.
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